{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10275",
      "entity_text" : "AR",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Successful clinical development of abiraterone and enzalutamide, both intended to target the AR LBD (which is missing in AR-Vs), is directly driven by laboratory mechanistic studies establishing intra-tumoral androgens and AR protein overexpression as the key molecular determinants of CRPC.",
  "reading_complete" : "2020-08-04T12:48:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:47:08Z",
  "trigger" : "overexpression",
  "evidence" : [ "AR protein overexpression" ],
  "pmc_id" : "4209743",
  "score" : 0
}